Pathophysiology, Aetiology and Treatment of Gastroparesis.
Diabetes
Digestion
Gastric emptying
Gastroparesis
Gut hormones
Journal
Digestive diseases and sciences
ISSN: 1573-2568
Titre abrégé: Dig Dis Sci
Pays: United States
ID NLM: 7902782
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
pubmed:
1
5
2020
medline:
21
10
2020
entrez:
1
5
2020
Statut:
ppublish
Résumé
Gastroparesis is characterized by delayed gastric emptying, with symptoms such as nausea, vomiting and abdominal pain, in the absence of mechanical obstruction. In most cases, it is idiopathic although diabetes mellitus is another leading cause. The physiology of gastric emptying is a complex process which is influenced by various inputs including the central nervous system, enteric nervous system and gut hormones. Developments in our understanding of gastroparesis have now demonstrated dysfunction in these systems, thus disrupting normal gastric emptying. Once mechanical obstruction is excluded, gastric scintigraphy remains the gold standard for diagnosis although wireless motility capsule and breath testing are alternative methods for diagnosis. Treatment for gastroparesis is challenging, and widely available therapies are often limited either by their poor evidence for efficacy or concerns over their long-term safety profile. Novel prokinetic agents have shown initial promise in clinical trials, and new endoscopic techniques such as gastric per-oral endoscopic myotomy are emerging. These new treatment modalities may provide an option in refractory gastroparesis with the adage of reduced morbidity compared to surgical treatments.
Identifiants
pubmed: 32350720
doi: 10.1007/s10620-020-06287-2
pii: 10.1007/s10620-020-06287-2
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM